SA
Log In
MDT
OverviewIntelligenceChart

Analyst Sentiment

Analysts lean bullish — 56% recommend buying.

Consensus Rating
Buy
25 analysts·High coverage
56%
Rating Distribution
Strong Buy
00%
Buy
1456%
Hold
1144%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 29% higher.

Bear Case
$95.00
+11%
Consensus
$110.75
+29%
Bull Case
$120.00
+40%
Price Range25 analysts
Low
Consensus
High
$95.00
$120.00
Current Target
Current Price
$85.65
Upside to Target
$25.10

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+6.27%
EPS+7.25%
FY2028
Rev+4.58%
EPS+7.23%
FY2029
Rev+4.89%
EPS+9.14%

Earnings Surprises

Recent Analyst Actions

Apr 15, 2026Truist Financial
Medtronic price target lowered to $95 from $103 at Truist
Target:$95.00
+9.3%from $86.88
Apr 13, 2026Mizuho Securities
Medtronic price target lowered to $120 from $125 at Mizuho
Target:$120.00
+38.3%from $86.75
Apr 9, 2026Evercore ISI
Medtronic price target lowered to $106 from $108 at Evercore ISI
Target:$106.00
+20.6%from $87.91
Mar 10, 2026Leerink Partners
Leerink Partners Reiterates Outperform Rating on Medtronic, Inc. (MDT): acquisition an "incremental positive"
Target:$119.00
+31.8%from $90.31
Mar 10, 2026Needham
Needham Reiterates Buy Rating on Medtronic, Inc. (MDT): "glad to see MDT increasingly pursue tuck-in acquisitions"
Target:$120.00
+33.0%from $90.21
Feb 18, 2026Robert W. Baird
Medtronic price target lowered to $100 from $103 at Baird
Target:$100.00
+3.7%from $96.41
Feb 18, 2026Barclays
Medtronic price target raised to $118 from $116 at Barclays
Target:$118.00
+22.4%from $96.41
Feb 9, 2026Needham
Medtronic upgraded to Buy from Hold at Needham
Target:$121.00
+17.6%from $102.90
Feb 4, 2026UBS
Medtronic price target raised to $104 from $103 at UBS
Target:$104.00
+0.6%from $103.38
Jan 30, 2026Wells Fargo
Medtronic resumed with an Overweight at Wells Fargo
Target:$114.00
+12.0%from $101.78
Jan 9, 2026Bernstein
Medtronic price target raised to $112 from $111 at Bernstein
Target:$112.00
+13.5%from $98.69
Jan 8, 2026Barclays
Medtronic price target raised to $116 from $111 at Barclays
Target:$116.00
+16.3%from $99.77
Dec 18, 2025Truist Financial
Medtronic price target lowered to $107 from $110 at Truist
Target:$107.00
+7.9%from $99.14
Dec 16, 2025Robert W. Baird
Medtronic price target lowered to $103 from $109 at Baird
Target:$103.00
+4.4%from $98.67
Nov 20, 2025Barclays
Medtronic price target raised to $111 from $109 at Barclays
Target:$111.00
+10.6%from $100.34
Nov 19, 2025Bernstein
Medtronic price target raised to $111 from $98 at Bernstein
Target:$111.00
+10.6%from $100.34
Nov 19, 2025Leerink Partners
Medtronic, Inc. (MDT) PT Raised to $120 at Leerink Partners
Target:$120.00
+19.0%from $100.80
Nov 19, 2025Jefferies
Medtronic, Inc. (MDT) PT Raised to $110 at Jefferies
Target:$110.00
+9.1%from $100.80
Nov 19, 2025Goldman Sachs
Goldman Sachs Upgrades Medtronic, Inc. (MDT) to Neutral
Target:$111.00
+10.1%from $100.80
Oct 31, 2025Bernstein
Bernstein SocGen Group Reiterates Outperform Rating on Medtronic, Inc. (MDT), can RDN be the biggest thing MDT ever does?
Target:$98.00
+7.5%from $91.17
Oct 15, 2025Truist Financial
Medtronic price target raised to $103 from $96 at Truist
Target:$103.00
+8.1%from $95.26
Oct 10, 2025RBC Capital
Medtronic price target raised to $111 from $103 at RBC Capital
Target:$111.00
+16.0%from $95.72
Aug 26, 2025Argus Research
Medtronic price target raised to $115 from $105 at Argus
Target:$115.00
+24.8%from $92.18
Jan 8, 2025Bernstein
Medtronic price target lowered to $93 from $97 at Bernstein
Target:$93.00
+12.5%from $82.68
Oct 15, 2024Robert W. Baird
Medtronic, Inc. (MDT) PT Raised to $96 at Baird
Target:$96.00
+6.7%from $90.01

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance